Disc Medicine Inc

For the period ended Jun 30, 2024. Filed Aug 8, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 8, 2024

IRON$81.26+3.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

	June 30,	December 31,
	2024	2023
Assets ·
Current assets: ·
Cash and cash equivalents	$280,663	$360,382
Marketable securities	220,282	—
Prepaid expenses and other current assets	7,296	5,280
Total current assets	508,241	365,662
Property and equipment, net	98	170
Right-of-use assets, operating leases	1,642	1,930
Other assets	236	234
Total assets	$510,217	$367,996
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$4,749	$12,629
Accrued external research and development expenses	10,351	1,986
Other accrued expenses	4,451	6,159
Operating lease liabilities, current	759	665
Total current liabilities	20,310	21,439
Operating lease liabilities, non-current	1,078	1,436
Total liabilities	21,388	22,875
Commitments and contingencies (Note 14)
Stockholders’ equity:
Common stock, $0.0001 par value; 100,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 29,707,997 and 24,360,233 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	3	2
Additional paid-in capital	730,832	533,764
Accumulated other comprehensive loss	(60)	—
Accumulated deficit	(241,946)	(188,645)
Total stockholders’ equity	488,829	345,121
Total liabilities and stockholders’ equity	$510,217	$367,996

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.